A team of researchers from the US and Japan compared 59 white males and 105 Japanese American males who had receive hormone treatment for prostate cancer at The Queen’s Medical Centre in Honolulu, Hawaii.
They discovered that, although there was little difference between the patients’ backgrounds and ages, five years after the treatment started the overall survival rate for the Japanese American patients was 66 per cent, compared with 42 per cent for the white men in the sample.
The result between the two ethnic groups did not appear to be affected by whether the men’s cancer was confined to the prostate or had spread to other parts of the body.
However the survival rates tended to even out in the most advanced cancers, when the levels of the Prostate-Specific Antigen (PSA) protein produced by the prostate exceeded 100. About a quarter of the study sample had PSA readings in this range.
“Japanese men have one of the lowest rates of prostate cancer worldwide, but levels tend to be higher among Japanese American men, compared with those who actually live in Japan” says lead author Dr Takashi Fukagai, a urologist at the Showa University School of Medicine in Tokyo.
“One theory is that Japanese Americans retain some native Japanese genetic and,or,lifestyle characteristics that lead to them developing prostate cancer less frequently than white American men.
“We also have a ongoing study of other ethnic groups, which has shown that Chinese men living in Hawaii have a similar prognosis to Japanese American men. We have also discovered that Filipino men have a worse prognosis than those two ethnic groups, but still enjoy a higher survival rate than white men.
The men who took part in the study had an average age of 76 and had all received hormonal treatment from the same team or urologists. Hormone therapy blocks the action of the male sex hormones that help the cancer cells grow, either through administering testosterone lowering drugs or by removing the testosterone-producing testicles.
None of the study subjects had received definitive surgical or radiation therapy.
Five factors were examined in detail – age, race, pre-treatment PSA score, the clinical stage that the cancer had reached and the Gleason score, which defines the severity of the cancer based on microscopic analysis.
Only two factors - race and the pre-treatment PSA score – were shown to have a significant effect on whether the patient survived and for how long.
“One of the reasons why the survival rate may be better among Japanese American men with a PSA of less than 100 is that they are less likely to suffer from the side-effects of the hormone treatment, such as heart problems, compared with white American males” adds Dr Fukagai.
“There is also evidence that different races have different genetic profiles. As prostate cancer is a disease that is affected by hormones, it may be that the nature of the actual disease, and how it progresses, varies between different races.
“However prostate cancer undergoes various changes as it develops and we suspect that the changes that take place in the advanced stages of the disease reduce the effect of those ethnic differences.
“This would account for the fact that there was a difference in survival rates between Japanese American and white men with a PSA of less than 100, but those ethnic differences disappeared in more severe cases with a PSA of more than 100.”
Annette Whibley | alfa
Antarctic Ice Sheet mass loss has increased
14.06.2018 | Technische Universität Dresden
WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf
Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...
Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.
Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...
The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.
Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.
An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.
Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...
Light detection and control lies at the heart of many modern device applications, such as smartphone cameras. Using graphene as a light-sensitive material for...
13.06.2018 | Event News
08.06.2018 | Event News
05.06.2018 | Event News
19.06.2018 | Physics and Astronomy
19.06.2018 | Life Sciences
19.06.2018 | Physics and Astronomy